Advertisement

Topics

Heplisav-B Vaccine for Hep B Finally Wins FDA Approval

12:28 EST 10 Nov 2017 | Medscape

Rejected twice before by the agency, the new vaccine must undergo a large postmarketing study on the risk for acute myocardial infarctions and immune-mediated diseases.
FDA Approvals

Original Article: Heplisav-B Vaccine for Hep B Finally Wins FDA Approval

NEXT ARTICLE

More From BioPortfolio on "Heplisav-B Vaccine for Hep B Finally Wins FDA Approval"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...